Vascular actions of natriuretic peptides. Cyclic GMP-dependent and -independent mechanisms.
about
N-terminal fragment of the prohormone brain-type natriuretic peptide (NT-proBNP), cardiovascular events, and mortality in patients with stable coronary heart diseaseNatriuretic peptide receptor-3 underpins the disparate regulation of endothelial and vascular smooth muscle cell proliferation by C-type natriuretic peptideDefinitive role for natriuretic peptide receptor-C in mediating the vasorelaxant activity of C-type natriuretic peptide and endothelium-derived hyperpolarising factorIdentification of new signaling components in the sensory epithelium of human saccule.Pseudomonas aeruginosa exotoxin Y is a promiscuous cyclase that increases endothelial tau phosphorylation and permeabilityEndogenous vascular synthesis of B-type and C-type natriuretic peptides in the rainbow trout.Atrial natriuretic peptide attenuates LPS-induced lung vascular leak: role of PAK1.Role of microtubules in attenuation of PepG-induced vascular endothelial dysfunction by atrial natriuretic peptide.New perspectives for the treatment of pulmonary hypertensionVascular relaxation induced by C-type natriuretic peptide involves the ca2+/NO-synthase/NO pathway.Epithelium integrity is crucial for the relaxant activity of brain natriuretic peptide in human isolated bronchi.Pathophysiology of the Behçet's DiseaseA new small molecule inhibitor of soluble guanylate cyclase.Vascular Tone Regulation Induced by C-Type Natriuretic Peptide: Differences in Endothelium-Dependent and -Independent Mechanisms Involved in Normotensive and Spontaneously Hypertensive RatsCardiac endocrine function is an essential component of the homeostatic regulation network: physiological and clinical implications.C-type natriuretic peptide and endothelium-dependent hyperpolarization in the guinea-pig carotid artery.Epac/Rap and PKA are novel mechanisms of ANP-induced Rac-mediated pulmonary endothelial barrier protection.Loss of systemic endothelial function post-PCI.Anti-neutral endopeptidase, natriuretic peptides disarrangement, and proteinuria onset in membranous nephropathy.Barrier enhancing signals in pulmonary edema.Novel investigational therapies for treating pulmonary arterial hypertension.Opposite effects of ANP receptors in attenuation of LPS-induced endothelial permeability and lung injury.VAMP-1, VAMP-2, and syntaxin-4 regulate ANP release from cardiac myocytes.Resistance to endotoxic shock in mice lacking natriuretic peptide receptor-AOverexpressed C-type natriuretic peptide serves as an early compensatory response to counteract extracellular matrix remodeling in unilateral ureteral obstruction rats.Protein Kinase C as Regulator of Vascular Smooth Muscle Function and Potential Target in Vascular Disorders.Phenotyping COPD exacerbations using imaging and blood-based biomarkers.N-terminal prob-type natriuretic peptide is a marker of vascular remodelling and subclinical atherosclerosis in asymptomatic hypertensives.Evolving Mechanisms of Vascular Smooth Muscle Contraction Highlight Key Targets in Vascular Disease.Neutral endopeptidase and natriuretic peptide receptors participate in the regulation of C-type natriuretic peptide expression in renal interstitial fibrosis.Protective effects of C-type natriuretic peptide on cisplatin-induced nephrotoxicity in mice.Interaction of atrial natriuretic peptide and ouabain in the myocardium.Predictors and prognosis for incident in-hospital heart failure in patients with preserved ejection fraction after first acute myocardial infarction: An observational study.
P2860
Q24607043-045AB032-F9C2-4F6E-9F7B-9190AD0226FFQ28570682-5EA8356D-A4B7-4C27-BC64-66ECF90F7332Q28582616-A5B26F42-529F-4C66-BA24-B6CF4CA0A8B8Q30474417-E237CC8A-ADA9-49A3-AFA1-CFFEEA494B93Q30523756-C7850F48-A61D-4EB1-9EA4-D5D77211DAA3Q33973358-C4034495-374E-4AE7-94B2-C66B6EAEE27AQ34305451-0317DC6F-C830-470E-99E8-CF74D730042DQ34715709-41152256-F1E9-4EE9-8543-C1C1741237D0Q34903204-4E10E4A3-52ED-4724-9A62-2848776BB25BQ35161211-2BAB3A34-F455-423E-AFBA-B1257F063712Q35195548-B4B86088-1AD7-4FE0-B7BD-3FDE6562A646Q35250982-38F6B7E3-C720-4BD3-8760-D9AE87F5C07CQ35743176-6B3492D3-B3FE-46F5-8026-E20B893B872DQ36218562-F82C32A0-A58D-475E-A903-FC0EBB9332DAQ36350919-93E7D1FF-B45C-4AC4-A791-E9F416AE77DFQ36381532-D22A9E58-F051-42FD-9A31-3BA3A4F5FF79Q36840420-D0556DA4-8C9D-4429-AC26-82E35CC111FBQ37196342-04B256B2-AAB1-4419-B476-05BD9EA1A8E2Q38070067-204819DA-1D83-48EC-901F-586B64AB98D7Q38110515-8315CD3E-A5F2-4C44-B1A2-360A23660238Q38612061-7808AABD-2F46-4BCF-A591-7CA1C2F8DB93Q41078913-C390580F-0566-42C8-A652-74183D005A62Q42414416-19FE394F-1049-4F98-83AC-A29C3AFD76B0Q42628566-FC78A318-7EC6-4F9E-B3D5-375AFEE6C94FQ46335588-C8590D46-D396-44FF-AB89-B59E358CD104Q47131231-F3DC4FB4-1237-46F0-A38C-F2BF78E196E8Q47641932-762EA4E9-2BA0-4F2B-8EC0-3F5F6893029DQ48347859-265B00E2-F04F-4EB7-BAF3-D81081FF7E66Q49923465-DD41EB6E-CC1A-4304-92DE-DA77E21E6696Q50506151-53310CA4-A5BE-4C95-8106-E5F790F99C21Q52955865-8CA70C7B-3A49-4832-996A-C4DE28787B00Q54484833-28319F5A-67A6-4248-977B-3D5900D96843Q55514967-B92CBA00-AFCD-4228-AC83-865E37079760
P2860
Vascular actions of natriuretic peptides. Cyclic GMP-dependent and -independent mechanisms.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Vascular actions of natriureti ...... t and -independent mechanisms.
@ast
Vascular actions of natriureti ...... t and -independent mechanisms.
@en
type
label
Vascular actions of natriureti ...... t and -independent mechanisms.
@ast
Vascular actions of natriureti ...... t and -independent mechanisms.
@en
prefLabel
Vascular actions of natriureti ...... t and -independent mechanisms.
@ast
Vascular actions of natriureti ...... t and -independent mechanisms.
@en
P1476
Vascular actions of natriureti ...... nt and -independent mechanisms
@en
P2093
Raymond J MacAllister
P2888
P356
10.1007/S00395-004-0459-6
P577
2004-01-23T00:00:00Z